EDGAR Filing Documents for 0001213900-22-017920

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001213900-22-017920

Filing Date

2022-04-04

Accepted

2022-04-04 17:19:43

Documents

Period of Report

2022-04-04

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN PRIVATE ISSUER	ea157994-6k_biondvaxpharm.htm	6-K	10582
2	BIONDVAX PRESENTATION DATED APRIL 4, 2022	ea157994ex99-1_biondvaxpharm.htm	EX-99.1	25475
3	GRAPHIC	ex99-1_001.jpg	GRAPHIC	115512
4	GRAPHIC	ex99-1_002.jpg	GRAPHIC	298212
5	GRAPHIC	ex99-1_003.jpg	GRAPHIC	75846
6	GRAPHIC	ex99-1_004.jpg	GRAPHIC	105239
7	GRAPHIC	ex99-1_005.jpg	GRAPHIC	166986
8	GRAPHIC	ex99-1_006.jpg	GRAPHIC	128993
9	GRAPHIC	ex99-1_007.jpg	GRAPHIC	138467
10	GRAPHIC	ex99-1_008.jpg	GRAPHIC	160871
11	GRAPHIC	ex99-1_009.jpg	GRAPHIC	105033
12	GRAPHIC	ex99-1_010.jpg	GRAPHIC	126043
13	GRAPHIC	ex99-1_011.jpg	GRAPHIC	145144
14	GRAPHIC	ex99-1_012.jpg	GRAPHIC	156045
15	GRAPHIC	ex99-1_013.jpg	GRAPHIC	100592
16	GRAPHIC	ex99-1_014.jpg	GRAPHIC	91376
17	GRAPHIC	ex99-1_015.jpg	GRAPHIC	89528
18	GRAPHIC	ex99-1_016.jpg	GRAPHIC	148851
19	GRAPHIC	ex99-1_017.jpg	GRAPHIC	141388
20	GRAPHIC	ex99-1_018.jpg	GRAPHIC	46580
21	GRAPHIC	ex99-1_019.jpg	GRAPHIC	117386
22	GRAPHIC	ex99-1_020.jpg	GRAPHIC	133613
23	GRAPHIC	ex99-1_021.jpg	GRAPHIC	86583
24	GRAPHIC	ex99-1_022.jpg	GRAPHIC	80023
25	GRAPHIC	ex99-1_023.jpg	GRAPHIC	162186
26	GRAPHIC	ex99-1_024.jpg	GRAPHIC	117938
27	GRAPHIC	ex99-1_025.jpg	GRAPHIC	160736
28	GRAPHIC	ex99-1_026.jpg	GRAPHIC	89819
	Complete submission text file	0001213900-22-017920.txt		4569754

Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000

Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529

BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)